PubMed ID: 19064855 Author(s): Klein BE, Knudtson MD, Brazy P, Lee KE, Klein R. Cystatin C, other markers of kidney disease, and incidence of age-related cataract. Arch Ophthalmol. 2008 Dec;126(12):1724-30. doi: 10.1001/archophthalmol.2008.502. PMID 19064855 Journal: …
Kleins Lab
Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050.
PubMed ID: 19064858 Author(s): Saaddine JB, Honeycutt AA, Narayan KM, Zhang X, Klein R, Boyle JP. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol. …
Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study.
PubMed ID: 19001224 Author(s): Peeters A, Magliano DJ, Stevens J, Duncan BB, Klein R, Wong TY. Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study. Arch Ophthalmol. 2008 Nov;126(11):1554-60. doi: …
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.
PubMed ID: 19068374 Author(s): Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008 …
The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study.
PubMed ID: 18672224 Author(s): Klein R, Meuer SM, Knudtson MD, Klein BE. The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study. Am J Ophthalmol. 2008 Nov;146(5):692-9. doi: 10.1016/j.ajo.2008.05.050. Epub 2008 Jul …
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.
PubMed ID: 18823656 Author(s): Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH, Bilous R, Sjølie AK; DIRECT Programme Study Group. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) …
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.
PubMed ID: 18823658 Author(s): Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, Bilous R, Chaturvedi N; DIRECT Programme Study Group. Effect of candesartan on progression and regression of retinopathy in type …
Physical activity, white blood cell count, and lung cancer risk in a prospective cohort study.
PubMed ID: 18843014 Author(s): Sprague BL, Trentham-Dietz A, Klein BE, Klein R, Cruickshanks KJ, Lee KE, Hampton JM. Physical activity, white blood cell count, and lung cancer risk in a prospective cohort study. Cancer Epidemiol …
Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis.
PubMed ID: 18539932 Author(s): Cheung N, Klein R, Wang JJ, Cotch MF, Islam AF, Klein BE, Cushman M, Wong TY. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. …